Acute urticaria treated with systemic glucocorticoids: An evidence-based review.

IF 1.6 4区医学 Q2 MEDICINE, GENERAL & INTERNAL

Australian Journal of General Practice Pub Date : 2025-07-01 DOI:10.31128/AJGP-04-24-7237

Andreia Lasca, Juliana Gomes, Ana Teresa Gorgulho de Pinho, Raquel Filipa Martins, Daniela Moreira

{"title":"Acute urticaria treated with systemic glucocorticoids: An evidence-based review.","authors":"Andreia Lasca, Juliana Gomes, Ana Teresa Gorgulho de Pinho, Raquel Filipa Martins, Daniela Moreira","doi":"10.31128/AJGP-04-24-7237","DOIUrl":null,"url":null,"abstract":"Background and objectives: Systemic glucocorticoids (GCs) are frequently used in the treatment of acute urticaria (AU) to reduce its duration and intensity. AU is a self-limited transient condition and might not require treatment in mild cases. This review aims to evaluate the most recent evidence on the benefit of using GCs in the treatment of uncomplicated AU.Method: Evidence-based research was conducted on clinical guidelines published in The National Institute for Health and Care Excellence, meta-analyses, systematic reviews and randomised controlled clinical trials (RCCT) in The Cochrane Library and PubMed. The medical subject headings (MeSH) terms used were 'urticaria' and 'glucocorticoids'.Results: The initial research resulted in a total of 23 articles, of which two RCCT met all inclusion criteria.Discussion: The initial research resulted in a total of 23 articles, of which two RCCT met all inclusion criteria.","PeriodicalId":54241,"journal":{"name":"Australian Journal of General Practice","volume":"54 7","pages":"484-489"},"PeriodicalIF":1.6000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Australian Journal of General Practice","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.31128/AJGP-04-24-7237","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}

引用次数: 0

Abstract

Background and objectives: Systemic glucocorticoids (GCs) are frequently used in the treatment of acute urticaria (AU) to reduce its duration and intensity. AU is a self-limited transient condition and might not require treatment in mild cases. This review aims to evaluate the most recent evidence on the benefit of using GCs in the treatment of uncomplicated AU.

Method: Evidence-based research was conducted on clinical guidelines published in The National Institute for Health and Care Excellence, meta-analyses, systematic reviews and randomised controlled clinical trials (RCCT) in The Cochrane Library and PubMed. The medical subject headings (MeSH) terms used were 'urticaria' and 'glucocorticoids'.

Results: The initial research resulted in a total of 23 articles, of which two RCCT met all inclusion criteria.

Discussion: The initial research resulted in a total of 23 articles, of which two RCCT met all inclusion criteria.

查看原文本刊更多论文

系统性糖皮质激素治疗急性荨麻疹：一项基于证据的综述。

背景和目的：全身性糖皮质激素（GCs）经常用于治疗急性荨麻疹（AU），以减少其持续时间和强度。AU是一种自限性的短暂性疾病，在轻度病例中可能不需要治疗。本综述旨在评价使用GCs治疗非复杂性AU的益处的最新证据。方法：基于美国国家健康与护理卓越研究所（The National Institute for Health and Care Excellence）发表的临床指南、meta分析、系统评价和Cochrane Library和PubMed的随机对照临床试验（RCCT）进行循证研究。使用的医学主题标题（MeSH）术语是“荨麻疹”和“糖皮质激素”。结果：初步研究共纳入23篇文章，其中2篇RCCT符合全部纳入标准。讨论：初步研究共纳入23篇文章，其中2篇RCCT符合所有纳入标准。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Australian Journal of General Practice Medicine-Family Practice

CiteScore

2.80

自引率

4.50%

发文量

284

期刊介绍： The Australian Journal of General Practice (AJGP) aims to provide relevant, evidence-based, clearly articulated information to Australian general practitioners (GPs) to assist them in providing the highest quality patient care, applicable to the varied geographic and social contexts in which GPs work and to all GP roles as clinician, researcher, educator, practice team member and opinion leader. All articles are subject to peer review before they are accepted for publication.